LVMUY-OTC 0 ACN-N -0.98 UNH-N -4.91 VALT-T 0.19 MART-T -0.15 VIDY-T 0.31 RPRX-Q 0.05
Isotechnnika Inc (ISA-T)

Isotechnnika Inc (ISA-T)

3 watching

0.00
0.00 (0.00%) 1d
0

Related posts

Nervous markets await Nvidia
DON'T BUY

Isotechnnika Inc(ISA-T)

Nov 18, 2008
Nothing fundamentally horrible about this company but it does have a small market cap, which is an out-of-favour sector. Small cap biotech sector is not a place to be.
Duncan StewartDuncan Stewart
No
Unlock Rating
$0.115

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Isotechnnika Inc(ISA-T)

Apr 14, 2005
Drug development. Burning up cash hand over fist. In sloppy markets you have to watch out. There's no earnings or fundamental support. Very early stages in drug development and will have to raise money, so will dilute shareholders.
Chris FernycChris Fernyc
No
Unlock Rating
$2.650

Stock price when the opinion was issued

biotechnology pharmaceutical
WEAK BUY

Isotechnnika Inc(ISA-T)

Jan 07, 2005
Their particular area of expertise is getting involved with drugs that are involved with transplants that reduce rejection. Outlook for the company is quite interesting. In phase 2 and 3 trials so they still have a ways to go. Speculative.
Robert FloydRobert Floyd
Owned
Unlock Rating
$2.180

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Isotechnnika Inc(ISA-T)

Jan 26, 2004
Has a better product than cyclosporine. This should create a great marketplace for them. With more results coming out in 2004, you should see the stock move-up quite nicely.
Mike WeirMike Weir
Owned
Unlock Rating
$2.900

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Isotechnnika Inc(ISA-T)

Dec 22, 2003
Thinks the stock should move up from this level. Have a good opportunity to bring their product to market. Should rally by the middle of 2004.
Mike WeirMike Weir
Owned
Unlock Rating
$2.670

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Isotechnnika Inc(ISA-T)

Sep 09, 2003
Solid growth company. Well along in clinical trials. Well run and the upside is pretty good. Some good partnerships. Good product. If you want a Cdn biotech, this is a good one.
Peter HodsonPeter Hodson
Unknown
Unlock Rating
$3.630

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Isotechnnika Inc(ISA-T)

Jul 04, 2003
An interesting little company. Good cash position. Strong management.
Robert FloydRobert Floyd
Owned
Unlock Rating
$3.480

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Isotechnnika Inc(ISA-T)

Mar 05, 2003
Has been able to meet ,ilestones.
Mike WeirMike Weir
Unknown
Unlock Rating
$3.100

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Isotechnnika Inc(ISA-T)

Jul 10, 2002
Strong joint venture. Should move up as the clinical trials go through.
Robert FloydRobert Floyd
Unknown
Unlock Rating
$4.050

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Isotechnnika Inc(ISA-T)

Jan 16, 2002
Prefers over Biomira.
Ray SteeleRay Steele
Unknown
Unlock Rating
$4.050

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

Isotechnnika Inc(ISA-T)

Nov 13, 2001
Good product and is in phase 2. Volatile.
Malvin SpoonerMalvin Spooner
Unknown
Unlock Rating
$4.480

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Isotechnnika Inc(ISA-T)

Nov 09, 2001
Well funded in their product line.
Robert FloydRobert Floyd
Unknown
Unlock Rating
$4.690

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Isotechnnika Inc(ISA-T)

May 04, 2001
Expects it to get some partners.
Malvin SpoonerMalvin Spooner
Unknown
Unlock Rating
$3.700

Stock price when the opinion was issued

biotechnology pharmaceutical
Showing 1 to 13 of 13 entries
  • «
  • ‹
  • 1
  • ›
  • »

Isotechnnika Inc(ISA-T) Rating

Ranking : 1 out of 5

Star iconStar empty iconStar empty iconStar empty iconStar empty icon

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Isotechnnika Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Isotechnnika Inc(ISA-T) Frequently Asked Questions

What is Isotechnnika Inc stock symbol?

Isotechnnika Inc is a OTC stock, trading under the symbol ISA-T on the (). It is usually referred to as or ISA-T

Is Isotechnnika Inc a buy or a sell?

In the last year, there was no coverage of Isotechnnika Inc published on Stockchase.

Is Isotechnnika Inc a good investment or a top pick?

Isotechnnika Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for Isotechnnika Inc.

Why is Isotechnnika Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Isotechnnika Inc worth watching?

In the last year, there was no coverage of Isotechnnika Inc published on Stockchase.

What is Isotechnnika Inc stock price?

On , Isotechnnika Inc (ISA-T) stock closed at a price of $.

Build our watch list

Sign in to track investments
you care about

Latest Buy Signals

AAXN-Q -2.24$684.59
RKLB-Q -2.59$20.51
ENB-T 0.51$64.3
CLF-N -0.15$7
PLTR-Q -1.85$117.3

Today's Top Picks

LVMUY-… 0$109.799
ACN-N -0.98$307.9
UNH-N -4.91$380.64
VALT-T 0.19$40.79
MART-T -0.15$22.75

Popular Articles

Latest Sell Signals

GOOG-Q -1.37$154.38
VRTX-Q -4.61$424.99
PLTR-Q -1.85$117.3
ZTS-N -2.42$159.27
ADBE-Q -0.71$383.28

Most Recent Experts

Stockchase Insights

Stockchase Insights

5i Research

Michael Hakes - CFA, MBA

Michael Hakes - CFA, MBA

Murray Wealth Group

Stephen Weiss, Founder, Short Hills Capital Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Jim Lebenthal

Jim Lebenthal

Cerity Partners

Brenda Vingiello, CIO, Sand Hill Global Advisors

Brenda Vingiello, CIO, Sand Hill Global Advisors

Sand Hill Global Advisors

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: hello@stockchase.com.

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© Stockchase Inc. by Wealthica